World Journal of Nuclear Medicine : Table of Contents

Home

About us

Editorial board

Ahead of print

Current issue

Archives

Submit article

Instructions

Contacts

Users Online: 447

Article Cited by others

ORIGINAL ARTICLE

¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy in patients with borderline low and discordant renal parameters: Treatment feasibility assessment by sequential estimation of triple parameters and filtration fraction

Naik Chinna, Basu Sandip

Year : 2018| Volume: 17| Issue : 1 | Page no: 12-20

This article has been cited by

1	Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

	Daphne M. V. Huizing,Else A. Aalbersberg,Michelle W. J. Versleijen,Margot E. T. Tesselaar,Iris Walraven,Max J. Lahaye,Berlinda J. de Wit–van der Veen,Marcel P. M. Stokkel

	Cancer Imaging. 2020; 20(1)

	[Pubmed] [Google Scholar] [DOI]

2	Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors

	Sandip Basu,Rahul V. Parghane,Rahul V. Kamaldeep,Sudipta Chakraborty

	Seminars in Nuclear Medicine. 2020;

	[Pubmed] [Google Scholar] [DOI]

3	Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms): Fundamentals and Salient Clinical Practice Points for Medical Oncologists

	Sandip Basu,Rahul Parghane,Rohit Ranade,Pradeep Thapa,Anant Ramaswamy,Vikas Ostwal,Bhawna Sirohi,Dipanjan Panda,Shailesh V Shrikhande

	Indian Journal of Medical and Paediatric Oncology. 2019; 40(02): 165

	[Pubmed] [Google Scholar] [DOI]